Kazuki Kanayama
- Aging top 10%
-
- Neuroendocrine Tumor Research Advances 4
-
- Pancreatic and Hepatic Oncology Research 3
- HER2/EGFR in Cancer Research 3
-
- Gastric Cancer Management and Outcomes 3
- Lung Cancer Treatments and Mutations 3
-
- Monoclonal and Polyclonal Antibodies Research 3
-
- Cancer and Skin Lesions 2
-
- Gastrointestinal disorders and treatments 2
- Co-authors
- Kazushi SugimotoRyuta MikawaMasataka SugimotoTadashi SatoYoshifumi HirokawaTaizo ShiraishiRyotaro HashizumeNaoshi Shimojo
- Partner nations
- JapanSwitzerlandGreece
In The Last Decade
Kazuki Kanayama
20 papers receiving 401 citations
Peers
Comparison fields: 5 of 66
- Aging 22
- Immunology and Allergy 37
- Physiology 116
- Immunology 77
- Cancer Research 53
Countries citing papers authored by Kazuki Kanayama
This map shows the geographic impact of Kazuki Kanayama's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Kazuki Kanayama with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Kazuki Kanayama more than expected).
Fields of papers citing papers by Kazuki Kanayama
This network shows the impact of papers produced by Kazuki Kanayama. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Kazuki Kanayama. The network helps show where Kazuki Kanayama may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Kazuki Kanayama, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 3 | |
| 2 | 2023 | 0 | |
| 3 | 2022 | 1 | |
| 4 | 2020 | 6 | |
| 5 | 2020 | 3 | |
| 6 | 2019 | 30 | |
| 7 | 2018 | 18 | |
| 8 | 2017 | 10 | |
| 9 | 2016 | 124 | |
| 10 | 2016 | 1 | |
| 11 | 2016 | 11 | |
| 12 | 2016 | 24 | |
| 13 | 2016 | 4 | |
| 14 | 2015 | 114 | |
| 15 | 2014 | 1 | |
| 16 | 2014 | 3 | |
| 17 | 2014 | 4 | |
| 18 | 2013 | 7 | |
| 19 | 2012 | 1 | |
| 20 | [A case of unresectable pancreatic cancer that responded to UFT chemotherapy]. | 1990 | 2 |
About Kazuki Kanayama
Kazuki Kanayama is a scholar working on Immunology and Allergy, Oncology and Hepatology, having authored 21 papers that have together received 401 indexed citations. Recurring topics across this work include Neuroendocrine Tumor Research Advances (4 papers), Pancreatic and Hepatic Oncology Research (3 papers), HER2/EGFR in Cancer Research (3 papers), Gastric Cancer Management and Outcomes (3 papers), Monoclonal and Polyclonal Antibodies Research (3 papers), Lung Cancer Treatments and Mutations (3 papers), Cancer and Skin Lesions (2 papers) and Gastrointestinal disorders and treatments (2 papers). The work is most often cited by research in Aging (22 citations), Immunology and Allergy (37 citations) and Physiology (116 citations). Kazuki Kanayama has collaborated with scholars based in Japan, Switzerland and Greece. Frequent co-authors include Kazushi Sugimoto, Ryuta Mikawa, Masataka Sugimoto, Tadashi Sato, Yoshifumi Hirokawa, Taizo Shiraishi, Ryotaro Hashizume, Naoshi Shimojo, Toshimichi Yoshida and Kyoko Imanaka‐Yoshida. Their work appears in journals such as Scientific Reports, Hypertension and Aging Cell.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.